Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.530
+0.030 (1.20%)
At close: Sep 30, 2026, 4:00 PM EDT
2.520
-0.010 (-0.40%)
After-hours: Sep 30, 2026, 5:45 PM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $205.79 million as of September 30, 2026. Its market cap has increased by 35.04% in one year.
Market Cap
205.79M
Enterprise Value
117.50M
1-Year Change
35.04%
Ranking
Category
Stock Price
$2.53
ChartMarket Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $205.79M, an increase of 360.80%. That is a compound annual growth rate of 17.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 205.79M | 81.36% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compugen | 225.44M |
| Cartesian Therapeutics | 224.19M |
| Entrada Therapeutics | 222.11M |
| Anavex Life Sciences | 220.62M |
| Protalix BioTherapeutics | 219.15M |
| Sol-Gel Technologies | 218.87M |
| Alector | 217.73M |
| Whitehawk Therapeutics | 213.21M |